This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A national public health organization is calling for Health Secretary Robert F. Kennedy Jr. to resign the federal post he assumed just weeks ago, citing “implicit and explicit bias and complete disregard for science.” Georges Benjamin, executive director of the American Public Health Association, said in a statement on Wednesday that concerns raised during Kennedy’s confirmation hearing last month have been realized, followed by massive reductions in staff at key health agen
By Kurt R. Karst The FDA Reduction-in-Force (Termination)or RIF(T)announced last week has resulted in countless stories in the press and on personal LinkedIn accounts from those RIFd. As the dust begins to settle and we all assess what this means for the future of FDA and the public health, generally, this blogger wanted to call out one particular division in the Office of Generic Drugs (OGD), funded by user fees under the Generic Drug User Fee Amendments (GDUFA), that was eradicated and what t
It's time for Drug Channels annual update of vertical integration among insurers, PBMs, specialty pharmacies, and healthcare services within U.S. drug channels. As you can see below, we have revised, renovated, and refurbished our infamous illustration of the major vertical business relationships among the largest companies. Proponents of these vertical integration arrangements argue that they create opportunities to mine healthcare costs.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
"Unlocking New Hope for Neurological Disorders As we continue to push the boundaries of medical innovation, I'm excited to share with you a game-changing development in the fight against neurological disorders. At the forefront of this revolution is AI-based drug repurposing. By leveraging cutting-edge technology, researchers are re-examining existing medications to identify new uses for treating conditions such as Alzheimer's, Parkinson's, and multiple sclerosis.
The $6.3 trillion wellness industry thrives on distrust of science, glorifying “natural” alternatives, and fear-based marketing. The result? Pseudoscience that’s not just harming human health. It’s killing animals, too, specifically via H5N1 bird flu. Holistic pet health influencers, organic farmers, and alternative medicine advocates embrace behaviors that increase the risk of viral transmission, paving the way for a potential human pandemic.
363
363
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
The $6.3 trillion wellness industry thrives on distrust of science, glorifying “natural” alternatives, and fear-based marketing. The result? Pseudoscience that’s not just harming human health. It’s killing animals, too, specifically via H5N1 bird flu. Holistic pet health influencers, organic farmers, and alternative medicine advocates embrace behaviors that increase the risk of viral transmission, paving the way for a potential human pandemic.
The Indian Society for Clinical Research (ISCR) has announced the appointment of Dr Seema Pai as President for the 20252028 term. Dr Pai succeeds Dr Sanish Davis, who served as President from 2021 to 2025. The new leadership team also includes Anirban Roychowdhury as Honorary General Secretary and Amita Bhave as Treasurer. Dr Pais appointment comes at a time when the clinical research sector in India is adapting to changes in technology and evolving regulatory structures.
The National Institute For Health and Care Excellence ( NICE )s has recommended a new combination treatment for advanced breast cancer patients. AstraZenecas Truqap (capivasertib) in combination with fulvestrant is indicated as a treatment option for around 1,100 UK adults with hormone receptor (HR)-positive HER2-negative breast cancer with certain genetic mutations.
How do pharma brands cut through the noise and bring the right audiences to their digital doorstep? As digital channels continue to expand, identifying and optimizing the best traffic drivers has become more critical than ever for pharma marketing teams. In this article, well unpack the most effective sources of website traffic in 2025from organic search to paid campaignsand explore how marketing leaders can turn clicks into meaningful engagement.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Last week’s layoffs across the Department of Health and Human Services left a significant casualty in the vast ecosystem of government-backed science: an entire division focused on researching pain. The reduction in force enacted last week by Health Secretary Robert F. Kennedy Jr. eliminated all but one full-time position, out of roughly a dozen, within the National Institutes of Health Office of Pain Policy and Planning, a unit devoted to coordinating pain-related research across t
To address growing demand from the pharmaceutical industry, Asahi Kasei has launched a new division, Asahi Kasei Life Science, effective from 1 April 2025. The new structure is designed to unify its bioprocess businesses and streamline services offered to pharmaceutical partners across drug development and manufacturing. Asahi Kasei Life Science now houses the companys bioprocess-related units, including Planova virus removal filters, Microfilters BioOptimal, and associated equipment used in the
Patient-Centric Approaches to Maintaining Brand Value As the pharmaceutical industry continues to evolve, one thing remains clear: patients are at the forefront of every decision. At DrugPatentWatch, we've seen firsthand how patient-centric approaches can make all the difference in maintaining brand value. In our latest blog post, we explore the importance of putting patients first in brand strategy.
The cancer biotech company Infinitopes has gained approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to evaluate its ITOP1 vaccine targeting oesophageal cancer. This marks the first ever trial to administer a cancer vaccine in a neoadjuvant setting while the primary tumour remains. With Clinical Trial Application (CTA) approval, the upcoming phase […] The post Infinitopes launches first-in-human trial of vaccine targeting oesophageal cancer appeared first on Phar
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
NHC Submits Comments on FDA Draft Guidance for AI/ML-Enabled Medical Devices (PDF) April 7, 2025 Dockets Management Staff U.S. Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 RE: Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations [FDA-2024-D-4488] Submitted via regulations.gov To Whom It May Concern, The National Health Council (NHC) appreciates the opportunity to submit comments on the Food and D
Health insurers in the private Medicare business have a big incentive to diagnose their members with lots of health conditions: The government pays them more money. A new study shows the extent to which the biggest player in that business, UnitedHealth Group , stands out from the rest for its prowess at raking in extra cash from that program. Medicare Advantage insurers pulled in an estimated $33 billion in additional payment from the government in 2021 as a result of these extra diagnoses
Biocon Biologics (BBL), a subsidiary of Biocon (BSE code: 532523, NSE: BIOCON), has announced that the U.S. Food and Drug Administration (FDA) has approved JOBEVNE (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab), for intravenous use. JOBEVNE is a recombinant humanised monoclonal antibody used in the treatment of multiple types of cancer. JOBEVNE functions as a vascular endothelial growth factor (VEGF) inhibitor.
Just spent the day diving into the world of biosimilars and regulatory considerations. Key takeaways from the article on DrugPatentWatch: Biosimilar extrapolation of indications is a complex process that requires a deep understanding of the regulatory landscape. The FDA has established a framework for evaluating biosimilarity, but there is still a lack of clarity around extrapolation.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the progression of Alzheimer’s disease over a period of at least 18 months. If approved by regulators, HMTM could be the first oral treatment for the disease that targets the tau protein. Conventionally, targeted therapies for Alzheimers focused on amyloid protein […] The post Research finds tablet effective in slowing progression of Alzheimers disease over 18 months appeared f
Robert F. Kennedy Jr. will likely delay his appearance before the Senate’s health committee by several weeks, even as he makes historic changes to the Department of Health and Human Services and contends with a surging measles outbreak. Senate health committee Chair Bill Cassidy (R-La.) and ranking member Bernie Sanders (I-Vt.) publicly asked the secretary to appear on April 10.
Steris Healthcare, a pharmaceutical company headquartered in Mumbai with operations in Navi Mumbai, has unveiled a 50 crore growth strategy aimed at expanding its manufacturing capacity, entering new regional markets, and launching an Initial Public Offering (IPO) in FY 202627. The company, which recently crossed 100 crore in annual revenue, plans to strengthen its national presence through a multi-pronged approach.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Process analytical technology (PAT), namely at-line, online or inline instruments, may be represented by univariate sensors or more complex analysers and systems resulting in multivariate datasets. These can be pivotal for achieving high precision, efficiency and control, as well as continuous and automated manufacturing. Here we provide an overview of the tasks involved in implementing PAT in a GMP environment, as well as opportunities for organisations to consider in the face of common challen
“There will be a ChatGPT moment for biotechnology,” a bipartisan commission wrote in the new report, which calls for the U.S. to invest at least $15 billion into the sector over the next five years.
Some 2.7 million patients could have saved on their prescription charges by using a pre-payment certificate (PPC) in 2023/24, latest analysis from the NHS Business Services Authority (NHSBSA) has suggested. For 61% of those, a three-month PPC may have been the best choice, saving each patient 16 on average, the NHSBSA said. And a further […] The post Millions could save on prescriptions using a pre-payment certificate, suggests NHSBSA appeared first on The Pharmacist.
“This year is going to be the year AI agents are going to get deployed,” NVIDIA CEO Jensen Huang declared at this year’s Consumer Electronics Show. But what are AI agents, and how do they apply to health care? Several health tech companies have jumped in on agents. One of the early entrants, Hippocratic AI, has a lineup of AI “nurses” that health systems can deploy for specific workflows, such as discussing cervical cancer screening or checking in on a chronic
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
The Federation of Pharma Entrepreneurs (FOPE), in collaboration with PharmaState Academy, conducted the 18th session of its ongoing PULSE (Pharma Upgradation & Learning Series for Excellence) initiative. The session focused on the manufacture of sterile drug products in line with the Revised Schedule M, bringing together key stakeholders and experts from across the pharmaceutical manufacturing ecosystem.
A new Digital Architecture framework is anticipated to help transform the process of manufacturing pharmaceuticals, by helping companies to progress towards autonomous manufacturing.The digitalisation-focused initiative is a collaborationbetween the Centre for Process Innovation (CPI) and industry partners including AstraZeneca and GSK. This framework delivers a clear strategy for companies to incorporate digital technologies, enable real-time release for drug manufacturing and address key chall
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
364 
Let's personalize your content